MXPA03005813A - Composicion farmaceutica para el tratamiento de fimosis usando corticosteroide topico. - Google Patents

Composicion farmaceutica para el tratamiento de fimosis usando corticosteroide topico.

Info

Publication number
MXPA03005813A
MXPA03005813A MXPA03005813A MXPA03005813A MXPA03005813A MX PA03005813 A MXPA03005813 A MX PA03005813A MX PA03005813 A MXPA03005813 A MX PA03005813A MX PA03005813 A MXPA03005813 A MX PA03005813A MX PA03005813 A MXPA03005813 A MX PA03005813A
Authority
MX
Mexico
Prior art keywords
phimosis
treatment
pharmaceutical composition
topical corticosteroid
topical
Prior art date
Application number
MXPA03005813A
Other languages
English (en)
Spanish (es)
Inventor
Cesar Rodriguez Palma Paulo
Original Assignee
Apsen Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica S A filed Critical Apsen Farmaceutica S A
Publication of MXPA03005813A publication Critical patent/MXPA03005813A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03005813A 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroide topico. MXPA03005813A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose
PCT/BR2001/000154 WO2002053137A2 (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid

Publications (1)

Publication Number Publication Date
MXPA03005813A true MXPA03005813A (es) 2005-02-14

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005813A MXPA03005813A (es) 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroide topico.

Country Status (12)

Country Link
US (1) US7666858B2 (enExample)
EP (1) EP1365766B1 (enExample)
JP (1) JP5095907B2 (enExample)
CN (1) CN1270719C (enExample)
AR (1) AR032208A1 (enExample)
AU (1) AU2002221365A1 (enExample)
BR (1) BR0006556A (enExample)
DE (1) DE60121047T2 (enExample)
ES (1) ES2267671T3 (enExample)
MX (1) MXPA03005813A (enExample)
RU (1) RU2279893C2 (enExample)
WO (1) WO2002053137A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
ES2441961T3 (es) * 2007-02-15 2014-02-07 Allergan, Inc. Composiciones de toxina botulínica y métodos
IN2013CN00342A (enExample) * 2010-06-17 2015-07-03 Nitto Denko Corp
DK2595624T3 (en) * 2010-07-20 2018-03-26 Halozyme Inc Methods of treating or preventing adverse side effects associated with administration of an anti-hyaluronan agent
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
JP5095907B2 (ja) 2012-12-12
EP1365766B1 (en) 2006-06-21
US7666858B2 (en) 2010-02-23
RU2279893C2 (ru) 2006-07-20
RU2003119439A (ru) 2005-02-27
HK1060850A1 (en) 2004-08-27
AR032208A1 (es) 2003-10-29
CN1487833A (zh) 2004-04-07
EP1365766A2 (en) 2003-12-03
AU2002221365A1 (en) 2002-07-16
WO2002053137A2 (en) 2002-07-11
BR0006556A (pt) 2002-09-17
ES2267671T3 (es) 2007-03-16
CN1270719C (zh) 2006-08-23
DE60121047D1 (de) 2006-08-03
JP2004519451A (ja) 2004-07-02
US20040067922A1 (en) 2004-04-08
WO2002053137A3 (en) 2003-04-24
DE60121047T2 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
Charman et al. The use of corticosteroids and corticosteroid phobia in atopic dermatitis
US7112578B2 (en) Methods and compositions for treatment of inflammatory disease
US20250360147A1 (en) Methods using combined oral contraceptive compositions with reduced cardiovascular effects
Morss‐Walton et al. Ostomy 101 for dermatologists: Managing peristomal skin diseases
Smith et al. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus
Pérez-López et al. EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women
US20020192273A1 (en) Therapeutic patch useful for the treatment of hemorrhoids
US7666858B2 (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
JPH02501739A (ja) ステロイドローション剤
WO2001041783A1 (en) Methods and compositions for treatment of inflammatory disease
AU600271B2 (en) Composition for arresting angiogenesis and capillary, cell or membrane leakage
JP2000229884A (ja) 皮膚外用剤
EP3476394A1 (en) Compositions for the treatment of ischemic ulcers and stretch marks
WO2016198997A1 (en) A medicinal cream made using betamethasone valerate and incorporating bio-polymer and a process to make the same
Keefe et al. Acute pancreatitis: a fatal complication of treatment of bullous pemphigoid with systemic corticosteroids
Lee et al. The modern topical steroid.
HK1060850B (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
Hall Lichen sclerosus: early diagnosis is the key to treatment
Miura et al. Autoeczematization: A Rare Complication of Contact Dermatitis Triggered by Topical Antibiotic Ointment
US20230381221A1 (en) Compositions and methods for treating pruritis ani and anal fissures
WO2016198998A1 (en) A medicinal cream made using clobetasol propionate and incorporating a biopolymer and a process to make it
SO Comparison of a New Medicinal Plant Extract and Triamcinolone Acetonide in Treatment of Recurrent Aphthous Stomatitis
Bra et al. Treatment of Balanitis Xerotica Obliterans with Topical Floucinolone Acetonide Cream
Polley et al. Treatment and care of genital lichen sclerosus
Lewis Drugs and the skin

Legal Events

Date Code Title Description
FG Grant or registration